Causing Colorant Hidden in Your Pantry Red dye 3 has been banned from use in topical drugs and cosmetics since 1990, when the ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center showing how optical genome mapping (OGM) can address ...

An update from Defence Therapeutics ( ($TSE:DTC) ) is now available. Defence Therapeutics announced a successful presentation at the World ADC ...

WASHINGTON — Joe Biden recently underwent skin cancer surgery, a spokesperson confirmed to USA TODAY, just months after the former president was diagnosed with prostate cancer. According to the ...

Victor Conte was at the heart of the biggest sports scandal in U.S. history in the early 2000s, which ensnared MLB stars, NFL players and Olympic champions ...

The start of the trial marks an expansion of the firm's oncology pipeline, and the firm hopes mRNA-2808 will be the first of many T-cell engagers in its portfolio.

Intensity Therapeutics ( INTS ), with a ~$13M market cap, closed up nearly 395% Thursday after publishing phase 1/2 results on its candidate for metastatic or refractory cancers, INT230-6.

Intensity Therapeutics Inc. company and executive profile by Barron's. View the latest INTS company infomation and executive bios.

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

Amphista Therapeutics Ltd. has divulged proteolysis targeting chimera (PROTAC) compounds comprising an F-Box only protein 22 (FBXO22)-binding moiety coupled to a transcriptional enhancer factor TEF ...

MIT researchers discovered that the genome’s 3D structure doesn’t vanish during cell division as previously thought. Instead, ...